Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG vs Technetium for SLN Biopsy in Pediatric Tumors
NCT02910726Phase 3Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 2016
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind, single-arm trial of indocyanine green in solid tumor, sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: % of Patients in Whom a Sentinel Lymph Node is Identified at 1 year. Started Sep 2016; status: completed.
02
Drugs
indocyanine green
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02910726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02910726.